XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument TG4 BE0003846632 OXURION N.V. EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument TG4 BE0003846632 OXURION N.V. EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 5LH0 SE0021181559 GUARD THERAPEUTICS INT.AB EQUITY wird ex Kapitalmassnahme gehandelt am 02.09.2024
The instrument 5LH0 SE0021181559 GUARD THERAPEUTICS INT.AB EQUITY is traded ex capital adjustment on 02.09.2024

Das Instrument HQ10 US00211Y5069 ARCA BIOPHARMA DL-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument HQ10 US00211Y5069 ARCA BIOPHARMA DL-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument FET KYG3307Z1090 FAR EAST CONS. INTL HD-10 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument FET KYG3307Z1090 FAR EAST CONS. INTL HD-10 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 4QI KYG982771092 XTEP INTL HOL.REGS HD-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument 4QI KYG982771092 XTEP INTL HOL.REGS HD-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 6LJ US5768101058 MATINAS BIOPH.HLD.DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument 6LJ US5768101058 MATINAS BIOPH.HLD.DL-,001 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument M5L GB00B0MT3Y97 MATTIOLI WOODS PLC LS-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument M5L GB00B0MT3Y97 MATTIOLI WOODS PLC LS-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument EJ7 AU000000ERA9 ENERGY RES. A EQUITY wird ex Kapitalmassnahme gehandelt am 02.09.2024
The instrument EJ7 AU000000ERA9 ENERGY RES. A EQUITY is traded ex capital adjustment on 02.09.2024

Zeit	Aktuelle Nachrichten
17.04.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Notice of Annual General Meeting/Proxy Form
11.04.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Compulsory Acquisition by Rio Tinto
11.04.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Compulsory Acquisition Notice
31.03.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Appendix 3Y - Justin Carey
31.03.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Appendix 3Y - Alfie Grigg

Zeit

Aktuelle Nachrichten

17.04.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Notice of Annual General Meeting/Proxy Form

11.04.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Compulsory Acquisition by Rio Tinto

11.04.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Compulsory Acquisition Notice

31.03.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Appendix 3Y - Justin Carey

31.03.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Appendix 3Y - Alfie Grigg

Zeit	Aktuelle Nachrichten
07.03.	FE CONSORT INTL (00035): INSIDE INFORMATION ENTERING INTO HEADS OF AGREEMENT WITH THE STAR
28.02.	FE CONSORT INTL (00035): DISCLOSEABLE TRANSACTION IN RELATION TO THE DISPOSAL OF SHARES IN BC INVESTMENT GROUP HOLDINGS LIMITED
25.02.	AMTD IDEA Group: AMTD Successfully Reached a Strategic Partnership With the Far East Consortium for the UK	AMTD IDEA Group ("AMTD"; NYSE: AMTD; SGX: HKB) has entered into a strategic partnership with Far East Consortium International Limited ("FEC", 0035.HK) for the UK to drive forward the future of the... ► Artikel lesen
25.02.	FE CONSORT INTL (00035): DISCLOSEABLE TRANSACTION INVOLVING HOTEL AND TOWN HALL IN THE UNITED KINGDOM
18.02.	FE CONSORT INTL (00035): NEXT DAY DISCLOSURE RETURN

Zeit

Aktuelle Nachrichten

07.03.

FE CONSORT INTL (00035): INSIDE INFORMATION ENTERING INTO HEADS OF AGREEMENT WITH THE STAR

28.02.

FE CONSORT INTL (00035): DISCLOSEABLE TRANSACTION IN RELATION TO THE DISPOSAL OF SHARES IN BC INVESTMENT GROUP HOLDINGS LIMITED

25.02.

AMTD IDEA Group: AMTD Successfully Reached a Strategic Partnership With the Far East Consortium for the UK

AMTD IDEA Group ("AMTD"; NYSE: AMTD; SGX: HKB) has entered into a strategic partnership with Far East Consortium International Limited ("FEC", 0035.HK) for the UK to drive forward the future of the...
► Artikel lesen

25.02.

FE CONSORT INTL (00035): DISCLOSEABLE TRANSACTION INVOLVING HOTEL AND TOWN HALL IN THE UNITED KINGDOM

18.02.

FE CONSORT INTL (00035): NEXT DAY DISCLOSURE RETURN

Zeit	Aktuelle Nachrichten
25.03.	Guard Therapeutics International AB: Two-thirds of patients enrolled in Guard Therapeutics' Phase 2b POINTER study	Guard Therapeutics announced today that it has reached another key milestone in its ongoing clinical development program. Two-thirds of the approximately 160 planned patients have now been enrolled... ► Artikel lesen
14.03.	XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025	Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen
10.03.	Guard Therapeutics International AB: The Board of Directors of Guard Therapeutics has resolved on a previously announced rights issue of approximately SEK 150 million	THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen
27.02.	Guard Therapeutics International AB: Guard Therapeutics announces positive outcome from first independent safety data review in Phase 2b POINTER study	Guard Therapeutics announced today that an independent Data Safety Monitoring Committee (DSMC) has completed its first planned review of safety data and has recommended that the Phase 2b clinical study... ► Artikel lesen

Zeit

Aktuelle Nachrichten

25.03.

Guard Therapeutics International AB: Two-thirds of patients enrolled in Guard Therapeutics' Phase 2b POINTER study

Guard Therapeutics announced today that it has reached another key milestone in its ongoing clinical development program. Two-thirds of the approximately 160 planned patients have now been enrolled...
► Artikel lesen

14.03.

XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025

Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY...
► Artikel lesen

10.03.

Guard Therapeutics International AB: The Board of Directors of Guard Therapeutics has resolved on a previously announced rights issue of approximately SEK 150 million

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA...
► Artikel lesen

27.02.

Guard Therapeutics International AB: Guard Therapeutics announces positive outcome from first independent safety data review in Phase 2b POINTER study

Guard Therapeutics announced today that an independent Data Safety Monitoring Committee (DSMC) has completed its first planned review of safety data and has recommended that the Phase 2b clinical study...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Fr	Vodafone, Maroc Telecom ink enterprise services deal
Fr	Vodafone Business and Maroc Telecom Partner to Boost Morocco's Digital Ambitions with Smart City Solutions
Fr	Maroc Telecom, Visa Partner to Expand Digital Payments in Africa
Fr	Maroc Telecom joins forces with Vodafone to provide better services to private & public sectors in Morocco
Do	Vodafone, Maroc Telecom ink enterprise pact

Zeit

Aktuelle Nachrichten

Vodafone, Maroc Telecom ink enterprise services deal

Vodafone Business and Maroc Telecom Partner to Boost Morocco's Digital Ambitions with Smart City Solutions

Maroc Telecom, Visa Partner to Expand Digital Payments in Africa

Maroc Telecom joins forces with Vodafone to provide better services to private & public sectors in Morocco

Vodafone, Maroc Telecom ink enterprise pact

Zeit	Aktuelle Nachrichten
Di	Matinas BioPharma files to sell 16.9M shares of common stock for holders
15.04.	Matinas BioPharma Holdings, Inc. - 10-K, Annual Report
04.04.	Matinas BioPharma Holdings, Inc. - 8-K, Current Report
31.03.	Matinas BioPharma Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
11.03.	Matinas BioPharma Holdings, Inc.: Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

Zeit

Aktuelle Nachrichten

Matinas BioPharma files to sell 16.9M shares of common stock for holders

15.04.

Matinas BioPharma Holdings, Inc. - 10-K, Annual Report

04.04.

Matinas BioPharma Holdings, Inc. - 8-K, Current Report

31.03.

Matinas BioPharma Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

11.03.

Matinas BioPharma Holdings, Inc.: Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

Zeit	Aktuelle Nachrichten
19.11.24	Mattioli Woods: Profit slashed at wealth manager as it quit London
02.09.24	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024		Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024 The instrument MSPA MA0000011488 ITISSALAT AL-MA.... ► Artikel lesen

Zeit

Aktuelle Nachrichten

19.11.24

Mattioli Woods: Profit slashed at wealth manager as it quit London

02.09.24

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

Zeit	Aktuelle Nachrichten
09.03.	Oruka Therapeutics zeigt Fortschritte trotz Verlusten
07.03.	Stifel maintains Buy rating on Oruka Therapeutics stock, $49 target
07.03.	Oruka Therapeutics, Inc.: Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting	Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support a dose interval of two to three times per year Equivalent potency to bimekizumab... ► Artikel lesen
06.03.	Oruka Therapeutics, Inc. Q4 Loss Narrows
06.03.	ARCA biopharma GAAP EPS of -$0.49 misses by $0.08

Zeit

Aktuelle Nachrichten

09.03.

Oruka Therapeutics zeigt Fortschritte trotz Verlusten

07.03.

Stifel maintains Buy rating on Oruka Therapeutics stock, $49 target

07.03.

Oruka Therapeutics, Inc.: Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting

Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support a dose interval of two to three times per year Equivalent potency to bimekizumab...
► Artikel lesen

06.03.

Oruka Therapeutics, Inc. Q4 Loss Narrows

06.03.

ARCA biopharma GAAP EPS of -$0.49 misses by $0.08

Zeit	Aktuelle Nachrichten
Fr	OXURION: Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025	LEUVEN, BELGIUM - April 25, 2025 - 6:30 pm, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces today that negotiations initiated in July 2024 concerning... ► Artikel lesen
11.04.	OXURION: Publication Annual Report - Annual Shareholders' Meeting	Leuven, BELGIUM - April 11, 2025 - 08:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, has today published its annual report for the financial... ► Artikel lesen
04.04.	OXURION: Postponement Annual Shareholders Meeting	Leuven, BELGIUM - April 4, 2025 - 02:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today made the following announcement regarding the financial... ► Artikel lesen
02.04.	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC	Leuven, BELGIUM - April 2, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen
27.03.	OXURION: Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC	Leuven, BELGIUM - March 27, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen

Zeit

Aktuelle Nachrichten

OXURION: Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025

LEUVEN, BELGIUM - April 25, 2025 - 6:30 pm, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces today that negotiations initiated in July 2024 concerning...
► Artikel lesen

11.04.

OXURION: Publication Annual Report - Annual Shareholders' Meeting

Leuven, BELGIUM - April 11, 2025 - 08:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, has today published its annual report for the financial...
► Artikel lesen

04.04.

OXURION: Postponement Annual Shareholders Meeting

Leuven, BELGIUM - April 4, 2025 - 02:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today made the following announcement regarding the financial...
► Artikel lesen

02.04.

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Leuven, BELGIUM - April 2, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

27.03.

OXURION: Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC

Leuven, BELGIUM - March 27, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

Zeit	Aktuelle Nachrichten
17.04.	BRIEF: Xtep reports mid-single-digit growth in first quarter
17.04.	XTEP INT'L (01368): OPERATIONAL UPDATE ON BUSINESS IN MAINLAND CHINA FOR THE FIRST QUARTER OF 2025
15.04.	XTEP Launches Global Run Campaign to Push Boundaries and Embrace the Unexpected	XIAMEN, China, April 15, 2025 /PRNewswire/ -- Leading professional sportswear brand XTEP has officially launched the XTEP Global Run campaign on April 15 to convey the brand's positioning... ► Artikel lesen
03.04.	XTEP INT'L (01368): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
03.04.	XTEP INT'L (01368): ANNUAL REPORT 2024

Zeit

Aktuelle Nachrichten

17.04.

BRIEF: Xtep reports mid-single-digit growth in first quarter

17.04.

XTEP INT'L (01368): OPERATIONAL UPDATE ON BUSINESS IN MAINLAND CHINA FOR THE FIRST QUARTER OF 2025

15.04.

XTEP Launches Global Run Campaign to Push Boundaries and Embrace the Unexpected

XIAMEN, China, April 15, 2025 /PRNewswire/ -- Leading professional sportswear brand XTEP has officially launched the XTEP Global Run campaign on April 15 to convey the brand's positioning...
► Artikel lesen

03.04.

XTEP INT'L (01368): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT

03.04.

XTEP INT'L (01368): ANNUAL REPORT 2024

Unternehmen / Aktien	Kurs	%
ENERGY RESOURCES OF AUSTRALIA LIMITED	0,001	0,00 %
FAR EAST CONSORTIUM INTERNATIONAL LTD	0,077	+4,05 %
GUARD THERAPEUTICS INTERNATIONAL AB	1,080	+4,85 %
MAROC TELECOM	9,750	+2,09 %
MATINAS BIOPHARMA HOLDINGS INC	0,054	0,00 %
MATTIOLI WOODS PLC	9,250	0,00 %
ORUKA THERAPEUTICS INC	9,050	-1,09 %
OXURION NV	0,060	-9,10 %
XTEP INTERNATIONAL HOLDINGS LTD	0,535	-1,83 %

Unternehmen / Aktien

Kurs

ENERGY RESOURCES OF AUSTRALIA LIMITED

0,001

0,00 %

FAR EAST CONSORTIUM INTERNATIONAL LTD

0,077

+4,05 %

GUARD THERAPEUTICS INTERNATIONAL AB

1,080

+4,85 %

MAROC TELECOM